Pillstats
Rx only · Kit

Norgestimate And Ethinyl Estradiol

Brands: Estarylla · Femynor · Mono-Linyah · Mili +15

16 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US47 NDCs
16 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCG03CA01
RxCUI (US)4124
US makers16 labelers
Packages76
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 26 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.036$0.072$0.108$0.144Dec 2025Apr 2026Jul 2026
$0.119
Latest avg · Jul 22, 2026
-4%
Since Dec 17, 2025
16
Active US suppliers
34%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

216K431K647K862K2025 Q12025 Q22025 Q32025 Q42026 Q1
615K
Rx · 2026 Q1
31.9M
Units dispensed
-18%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it16 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Aurobindo Pharma Limitedunknown18SUPPLYING
NorthStar Rx LLCunknown8SUPPLYING
Mayne Pharma Inc.unknown8SUPPLYING
Proficient Rx LPunknown7SUPPLYING
A-S Medication Solutionsunknown5SUPPLYING
Afaxys Pharma, LLCunknown5SUPPLYING
Xiromed, LLC.unknown3SUPPLYING
AvKAREunknown3SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown3SUPPLYING
Lupin Pharmaceuticals,Inc.unknown3SUPPLYING
Bryant Ranch Prepackrepackager3SUPPLYING
PD-Rx Pharmaceuticals, Inc.unknown2SUPPLYING
Amneal Pharmaceuticals LLCunknown2SUPPLYING
Glenmark Pharmaceuticals Inc., USAunknown2SUPPLYING
Preferred Pharmaceuticals Inc.unknown2SUPPLYING

+ 1 more labelers

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Sep 2, 2025
    RECALLRecall (Class II): Norgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg, 3 Units, 3x…

    Failed Content Uniformity Specifications — Recalling firm: AvKARE — U.S. Nationwide

  • Mar 7, 2024
    RECALLRecall (Class II): Tri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets USP - triphasic regimen, packaged in carton containing 3 B…

    Failed Dissolution Specifications — Recalling firm: Teva Pharmaceuticals USA, Inc — USA nationwide.

  • Mar 15, 2021
    RECALLRecall (Class II): TRI-LO-MARZIA 0.180MG/0.025MG; 0.215 MG/0.025MG AND 0.250MG/0.025MG 3X28 BPK; NDC/UPC 68180-837-73; RX; TABLETS

    CGMP Deviations: Intermittent exposure to temperature excursion during storage. — Recalling firm: Cardinal Health Inc. — FL, GA, SC